|
US5136019A
(en)
*
|
1989-05-24 |
1992-08-04 |
Sri International |
Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US7102999B1
(en)
*
|
1999-11-24 |
2006-09-05 |
Juniper Networks, Inc. |
Switching device
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
AR048098A1
(es)
|
2004-03-15 |
2006-03-29 |
Wyeth Corp |
Conjugados de caliqueamicina
|
|
JP2008505059A
(ja)
|
2004-05-06 |
2008-02-21 |
コンジュシェム バイオテクノロジーズ インコーポレイティド |
特異的ウイルス標的用化合物
|
|
AR056857A1
(es)
*
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
JP2010528285A
(ja)
|
2007-05-23 |
2010-08-19 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
免疫組織化学およびｉｎｓｉｔｕハイブリダーゼーションのためのポリマー担体
|
|
EP2276506A4
(en)
|
2008-04-30 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
|
KR101000067B1
(ko)
|
2008-12-30 |
2010-12-10 |
엘지전자 주식회사 |
고효율 태양전지용 레이저 소성장치 및 고효율 태양전지 제조방법
|
|
DK2528625T3
(da)
|
2010-04-15 |
2013-10-14 |
Spirogen Sarl |
Pyrrolobenzodiazepiner og konjugater deraf
|
|
US20130244905A1
(en)
|
2010-07-06 |
2013-09-19 |
Ed Grabczyk |
Reporter for RNA Polymerase II Termination
|
|
KR20140037105A
(ko)
|
2011-05-27 |
2014-03-26 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
CA2850103C
(en)
|
2011-10-14 |
2019-09-10 |
Spirogen Sarl |
Pyrrolobenzodiazepines
|
|
CA2850096C
(en)
|
2011-10-14 |
2018-07-03 |
Spirogen Sarl |
Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
|
|
WO2013055993A1
(en)
|
2011-10-14 |
2013-04-18 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
ES2945932T3
(es)
|
2011-10-14 |
2023-07-10 |
Seagen Inc |
Pirrolobenzodiazepinas y conjugados dirigidos
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
FI2911699T4
(fi)
|
2012-10-23 |
2025-12-09 |
Synaffix Bv |
Muokattu vasta-aine, vasta-ainekonjugaatti ja menetelmä niiden valmistamiseksi
|
|
MX379256B
(es)
|
2013-03-15 |
2025-03-10 |
Regeneron Pharma |
Moleculas biologicamente activas, conjugados de las mismas, y usos terapeuticos.
|
|
US9260182B2
(en)
*
|
2013-10-30 |
2016-02-16 |
Westjet Airlines Ltd. |
Integrated communication and application system for aircraft
|
|
RS59144B1
(sr)
*
|
2013-11-13 |
2019-09-30 |
Vertex Pharma |
Inhibitori replikacije virusa influence
|
|
US10639370B2
(en)
*
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
JP6712428B2
(ja)
*
|
2014-02-04 |
2020-06-24 |
コントラフェクト コーポレイション |
インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
|
|
EA201691945A1
(ru)
*
|
2014-03-27 |
2017-02-28 |
Дженентек, Инк. |
Антитела к гемагглютинину вируса гриппа типа b и способы их применения
|
|
US20160175224A1
(en)
*
|
2014-12-19 |
2016-06-23 |
Johnson & Johnson Consumer Companies, Inc. |
Antiperspirant composition
|
|
TWI702229B
(zh)
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
BR112017022550B1
(pt)
*
|
2015-04-28 |
2021-02-23 |
Shionogi & Co., Ltd |
derivados policíclicos de piridona substituída
|
|
AU2016374416A1
(en)
*
|
2015-12-15 |
2018-06-14 |
Shionogi & Co., Ltd. |
Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug
|
|
CN106589126A
(zh)
*
|
2016-12-07 |
2017-04-26 |
中国药科大学 |
一种抗人cd24抗体突变体的设计及其应用
|
|
LT3638698T
(lt)
|
2018-01-26 |
2021-04-12 |
Regeneron Pharmaceuticals, Inc. |
Antikūnai prieš tmprss2 ir antigeną surišantys fragmentai
|
|
CN112672762B
(zh)
*
|
2018-07-26 |
2025-06-13 |
普渡研究基金会 |
用于抗流感化学治疗和免疫治疗的小分子配体靶向药物缀合物
|
|
TWI861205B
(zh)
*
|
2019-09-06 |
2024-11-11 |
美商席達拉醫療有限公司 |
用於治療病毒感染之組合物及方法
|